2011-03-18                     House Journal                      Page 0505
HJR 8                                                                                                                         
The Resources Committee considered:                                                                                             
                                                                                                                                
     HOUSE JOINT RESOLUTION NO. 8                                                                                               
     Urging the United States Food and Drug Administration to deny                                                              
     an application to sell genetically engineered salmon in the United                                                         
     States; urging compliance with the provision of P.L. 110-85 (Food                                                          
     and Drug Administration Amendments Act of 2007) that requires                                                              
     the Commissioner of Food and Drugs to consult with the National                                                            
     Marine Fisheries Service of the National Oceanic and                                                                       
     Atmospheric Administration regarding a report on environmental                                                             
     risks associated with genetically engineered seafood products; and                                                         
     urging that product labeling requirements include the words                                                                
     "Genetically Modified" prominently displayed on the front of the                                                           
     package if the application is approved by the United States Food                                                           
     and Drug Administration.                                                                                                   
                                                                                                                                
and recommends it be replaced with:                                                                                             
                                                                                                                                

2011-03-18                     House Journal                      Page 0506
     CS FOR HOUSE JOINT RESOLUTION NO. 8(RES)                                                                                   
     Urging the United States Food and Drug Administration to deny                                                              
     any application to sell genetically engineered salmon in the United                                                        
     States; urging compliance with the provision of P.L. 110-85 (Food                                                          
     and Drug Administration Amendments Act of 2007) that requires                                                              
     the Commissioner of Food and Drugs to consult with the National                                                            
     Marine Fisheries Service of the National Oceanic and                                                                       
     Atmospheric Administration regarding a report on environmental                                                             
     risks associated with genetically engineered seafood products; and                                                         
     urging that product labeling requirements include the words                                                                
     "Genetically Modified" prominently displayed on the front of the                                                           
     package if the application is approved by the United States Food                                                           
     and Drug Administration.                                                                                                   
                                                                                                                                
The report was signed by Representatives Feige and Seaton, Co-                                                                  
chairs, with the following individual recommendations:                                                                          
                                                                                                                                
Do pass (6):  Gardner, P. Wilson, Herron, Kawasaki, Feige, Seaton                                                               
                                                                                                                                
                                                                                                                                
The following fiscal note(s) apply to CSHJR 8(RES):                                                                             
                                                                                                                                
1.  Zero, Legislative Agency                                                                                                    
                                                                                                                                
HJR 8 was referred to the Rules Committee for placement on the                                                                  
calendar.